|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_ocn923273498 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
151010s1993 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d XFH
|d ZCU
|d OCLCO
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCLCF
|d OCLCO
|d ICG
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d DKC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 994554202
|
| 020 |
|
|
|a 9780309593144
|
| 020 |
|
|
|a 030959314X
|
| 020 |
|
|
|a 0309050847
|
| 020 |
|
|
|a 9780309050845
|
| 029 |
1 |
|
|a DEBBG
|b BV044108293
|
| 035 |
|
|
|a (OCoLC)923273498
|z (OCoLC)994554202
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a RA644.A25.W6643 1993eb
|
| 082 |
0 |
4 |
|a 362.29
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Staff, National Research Council.
|
| 245 |
1 |
0 |
|a Workshop on Needle Exchange and Bleach Distribution Programs Proceedings.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 1993.
|
| 300 |
|
|
|a 1 online resource (320 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ""Proceedings Workshop on Needle Exchange and Bleach Distribution Programs""; ""Copyright""; ""Contents""; ""PREFACE""; ""INTRODUCTION""; ""REFERENCES""; ""U.S. NEEDLE EXCHANGE DATA""; ""The University of California Needle Exchange Program Evaluation Project: Methods, Conclusions, and Recommendation ""; ""METHODS""; ""Project Personnel""; ""Goal and Research Questions""; ""Ensuring Community and Expert Input""; ""Advisory Committee""; ""Expert Reviewers""; ""Kaiser Family Foundation Forum""; ""Consent and Confidentiality""; ""Formal Review of Existing Research""; ""Assessment of Data Needs""
|
| 505 |
8 |
|
|a ""Data Collection""""Data Synthesis""; ""Site Visits""; ""Identification of Sites and Interviewees""; ""Methodological Framework""; ""Training""; ""Site Observations""; ""Key Informant Interviews""; ""IDU Focus Groups""; ""Qualitative Analysis""; ""Mail Survey of NEPs Not Visited""; ""Cost-Effectiveness Modeling""; ""CONCLUSIONS""; ""How and Why Did NEPs Develop?""; ""How Do NEPs Operate?""; ""Do NEPs Act as Bridges to Public Health Services?""; ""How Much Does it Cost to Operate NEPs?""; ""Who Are the IDUs Who Use NEPs?""; ""What Proportion of All IDUs in a Community Uses the NEP?""
|
| 505 |
8 |
|
|a ""What Are the Community Responses to NEPs?""""Do NEPs Result in Changes in Community Levels of Drug Use?""; ""Do NEPs Affect the Number of Discarded Syringes?""; ""Do NEPs Affect Rates of HIV Drug and/or Sex Risk Behaviors?""; ""What is the Role of Studies of Syringes in Injection Drug Use Research?""; ""Do NEPs Affect Rates of Diseases Related to Injection Drug Use Other than HIV?""; ""Do NEPs Affect HIV Infection Rates?""; ""Are NEPs Cost-effective in Preventing HIV Infection?""; ""RECOMMENDATIONS""; ""Recommendations for the Federal Government""; ""Recommendations for State Governments""
|
| 505 |
8 |
|
|a ""Recommendations for Researchers""""APPENDIX""; ""Research Questions""; ""References""; ""Risk for Human Immunodeficiency Virus and Hepatitis B Virus in Users of the Tacoma Syringe Exchange Program""; ""INTRODUCTION""; ""METHODS""; ""The Intervention""; ""Studies of Risk Behavior in Local IDUs""; ""Surveillance of Blood-Borne Viral Infections""; ""Case-Control Study of Incident HBV Infections""; ""RESULTS""; ""DISCUSSIONS""; ""References""; ""Behavioral and Community Impact of the Portland Syringe Exchange Program""; ""PROGRAM OVERVIEW""; ""METHODS""; ""RESULTS""; ""CONCLUSIONS""
|
| 505 |
8 |
|
|a ""ACKNOWLEDGMENTS""""Reference""; ""New York City Syringe Exchange: An Overview""; ""INTRODUCTION""; ""OVERVIEW OF EVALUATION""; ""METHODS""; ""Ethnographic Study""; ""Behavioral Change and Seroconversion""; ""Seroprevalence and Seroincidence""; ""RESULTS""; ""Organizational-System Issues""; ""Health Departments""; ""The American Foundation for AIDS Research (AmFAR)""; ""Syringe Exchange Programs""; ""Evaluation""; ""PROBLEM SOLVING""; ""Subject Characteristics""; ""Self-Reported Change in Risk-Taking Behavior""; ""DISCUSSION""; ""ACKNOWLEDGMENTS""; ""References""
|
| 500 |
|
|
|a ""Discussion: U.S. Needle Exchange Data""
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Needle exchange programs
|x Health aspects
|z United States.
|
| 650 |
|
0 |
|a Intravenous drug abuse
|z United States
|x Prevention.
|
| 650 |
|
0 |
|a AIDS (Disease)
|z United States.
|
| 650 |
|
0 |
|a Chlorine and derivatives as disinfectants.
|
| 650 |
|
0 |
|a Needle exchange programs.
|
| 650 |
|
0 |
|a Disinfection and disinfectants.
|
| 650 |
|
0 |
|a Diseases.
|
| 650 |
|
0 |
|a Anti-infective agents.
|
| 650 |
|
0 |
|a Immunological deficiency syndromes.
|
| 650 |
|
0 |
|a Lentivirus infections.
|
| 650 |
|
0 |
|a Retrovirus infections.
|
| 650 |
|
0 |
|a Immunologic diseases.
|
| 650 |
|
0 |
|a Mental illness.
|
| 650 |
|
0 |
|a Sexually transmitted diseases.
|
| 650 |
|
0 |
|a National health services.
|
| 650 |
|
0 |
|a Virus diseases.
|
| 650 |
|
0 |
|a Medical care.
|
| 650 |
|
0 |
|a HIV infections.
|
| 650 |
|
0 |
|a Intravenous drug abuse.
|
| 650 |
|
2 |
|a Needle-Exchange Programs
|
| 650 |
|
2 |
|a Disinfectants
|
| 650 |
|
2 |
|a Disease
|
| 650 |
|
2 |
|a Sexually Transmitted Diseases, Viral
|
| 650 |
|
2 |
|a Substance-Related Disorders
|
| 650 |
|
2 |
|a Specialty Uses of Chemicals
|
| 650 |
|
2 |
|a Anti-Infective Agents
|
| 650 |
|
2 |
|a Immunologic Deficiency Syndromes
|
| 650 |
|
2 |
|a Lentivirus Infections
|
| 650 |
|
2 |
|a Preventive Health Services
|
| 650 |
|
2 |
|a Retroviridae Infections
|
| 650 |
|
2 |
|a Immune System Diseases
|
| 650 |
|
2 |
|a Mental Disorders
|
| 650 |
|
2 |
|a Community Health Services
|
| 650 |
|
2 |
|a Sexually Transmitted Diseases
|
| 650 |
|
2 |
|a Chemical Actions and Uses
|
| 650 |
|
2 |
|a Therapeutic Uses
|
| 650 |
|
2 |
|a Health Services
|
| 650 |
|
2 |
|a Psychiatry and Psychology
|
| 650 |
|
2 |
|a Health Care Facilities, Manpower, and Services
|
| 650 |
|
2 |
|a Pharmacologic Actions
|
| 650 |
|
2 |
|a Virus Diseases
|
| 650 |
|
2 |
|a Chemicals and Drugs
|
| 650 |
|
2 |
|a RNA Virus Infections
|
| 650 |
|
2 |
|a Delivery of Health Care
|
| 650 |
|
2 |
|a HIV Infections
|
| 650 |
|
2 |
|a Substance Abuse, Intravenous
|
| 650 |
|
2 |
|a Patient Care
|
| 650 |
|
6 |
|a Sida
|z États-Unis.
|
| 650 |
|
6 |
|a Chlore (Désinfectant)
|
| 650 |
|
6 |
|a Échange de seringues.
|
| 650 |
|
6 |
|a Désinfectants.
|
| 650 |
|
6 |
|a Maladies.
|
| 650 |
|
6 |
|a Toxicomanie.
|
| 650 |
|
6 |
|a Antiinfectieux.
|
| 650 |
|
6 |
|a Syndromes de déficit immunitaire.
|
| 650 |
|
6 |
|a Infections à lentivirus.
|
| 650 |
|
6 |
|a Infections à rétrovirus.
|
| 650 |
|
6 |
|a Maladies immunologiques.
|
| 650 |
|
6 |
|a Maladies mentales.
|
| 650 |
|
6 |
|a Infections transmissibles sexuellement.
|
| 650 |
|
6 |
|a Services de santé.
|
| 650 |
|
6 |
|a Maladies à virus.
|
| 650 |
|
6 |
|a Prestation de soins.
|
| 650 |
|
6 |
|a Infections à VIH.
|
| 650 |
|
6 |
|a Toxicomanie par voie veineuse.
|
| 650 |
|
6 |
|a Soins médicaux.
|
| 650 |
|
7 |
|a disinfectant.
|2 aat
|
| 650 |
|
7 |
|a mental disorders.
|2 aat
|
| 650 |
|
7 |
|a Virus diseases
|2 fast
|
| 650 |
|
7 |
|a Sexually transmitted diseases
|2 fast
|
| 650 |
|
7 |
|a Retrovirus infections
|2 fast
|
| 650 |
|
7 |
|a Needle exchange programs
|2 fast
|
| 650 |
|
7 |
|a National health services
|2 fast
|
| 650 |
|
7 |
|a Mental illness
|2 fast
|
| 650 |
|
7 |
|a Medical care
|2 fast
|
| 650 |
|
7 |
|a Lentivirus infections
|2 fast
|
| 650 |
|
7 |
|a Intravenous drug abuse
|2 fast
|
| 650 |
|
7 |
|a Immunological deficiency syndromes
|2 fast
|
| 650 |
|
7 |
|a Immunologic diseases
|2 fast
|
| 650 |
|
7 |
|a HIV infections
|2 fast
|
| 650 |
|
7 |
|a Disinfection and disinfectants
|2 fast
|
| 650 |
|
7 |
|a Diseases
|2 fast
|
| 650 |
|
7 |
|a Anti-infective agents
|2 fast
|
| 650 |
|
7 |
|a AIDS (Disease)
|2 fast
|
| 650 |
|
7 |
|a Chlorine and derivatives as disinfectants
|2 fast
|
| 650 |
|
7 |
|a Intravenous drug abuse
|x Prevention
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| 700 |
1 |
|
|a Staff, Institute of Medicine.
|
| 776 |
0 |
8 |
|i Print version:
|a Staff, National Research Council.
|t Workshop on Needle Exchange and Bleach Distribution Programs Proceedings.
|d Washington : National Academies Press, ©1993
|z 9780309050845
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3377839
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3377839
|
| 994 |
|
|
|a 92
|b IZTAP
|
